◆ NeutralEXSNY
Exosens relève ses objectifs pour l’exercice 2026, grâce à une montée en cadence plus rapide que prévu des capacités de production et à une forte dynamique commerciale
GlobeNewswire Inc.·
Exosens has raised its 2026 financial targets, projecting revenue of €558-570 million (up from €520-540 million) and adjusted EBITDA of €186-192 million (up from €168-178 million). The upgrade is driven by faster-than-expected production capacity increases for high-performance image intensifier tubes in Europe, strong demand for night vision solutions, accelerated adoption of imaging technologies for drone and surveillance applications, and robust nuclear instrumentation demand linked to next-generation SMRs.
Read Full Article at GlobeNewswire Inc. →